The findings revealed an 80% genetic alteration rate of SLC14A1 in CRC tissues, manifested primarily as upregulation and downregulation of mRNA, while the genetic alteration rate for SLC14A2 stood at a mere 4% (Fig. 1I). This evidence concerns the gene SLC14A2 and colorectal carcinoma.